Results 51 to 60 of about 404,841 (308)
Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils [PDF]
, 2017 INTRODUCTION: Asthma with adult onset and elevated blood eosinophils is a difficult-to-treat subgroup. This post hoc analysis evaluated reslizumab, an anti-interleukin-5 monoclonal antibody, in patients with late-onset eosinophilic asthma.
Brusselle, Guy +3 more
core +2 more sources
Detection of helicobacter pylori in nasal polyps using rapid urease test and ELISA [PDF]
Iranian Journal of Otorhinolaryngology, 2009 Introduction: Nasal polyposis is an inflammatory condition of unknown etiology. Recently concerns regarding gastroesophageal reflux or helicobacter pylori as a possible pathologic cause of nasal polyps have been increasing.
Masood Kaviani +4 more
doaj
Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review
Brazilian Journal of OtorhinolaryngologyIntroduction: Chronic rhinosinusitis with nasal polyps is a multifactorial disease with a complex pathophysiology involving multiple genetic and environmental factors.
Vanessa Ramos Pires Dinarte +7 more
doaj +1 more source
Cowden syndrome - Diagnostic skin signs [PDF]
, 2001 Cowden syndrome is a rare autosomal dominant familial cancer syndrome with a high risk of breast cancer. The most important clinical features include carcinomas of the breast and thyroid, and hamartomatous polyps of the gastrointestinal tract.
Burgdorf, Walter H. C. +2 more
core +1 more source
Sphenochoanal polyps in children — a systematic review (1995‒2021)
Brazilian Journal of Otorhinolaryngology, 2022 Objectives: Nasal polyps that originate from the sphenoid sinus and reach the nasopharynx are called sphenochoanal polyps. Reports on sphenochoanal polyps in children have thus far been limited only to case reports.
Krystian Tywoniuk +2 more
doaj +1 more source
Nasal polyp – an incidental paraganglioma [PDF]
Turkish Journal of Pathology, 2013 The nose is an uncommon site for head and neck paraganglioma. The diagnosis is seldom established pre-operatively; its rarity, infrequent functionality and often benign biologic outcome underlie this fact. We present one such case in a 60-year-old man who presented with right nasal obstruction and episodic epistaxis.
Urvashi Razdan +3 more
openaire +3 more sources
Asthma referrals : a key component of asthma management that needs to be addressed [PDF]
, 2017 Peer reviewedPublisher ...
Bergen, David A +3 more
core +1 more source
The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan
The Laryngoscope, 2020 Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the ...
S. Fujieda +10 more
semanticscholar +1 more source
Type 2 Innate Lymphoid Cells in Allergic Disease. [PDF]
, 2013 Type II innate lymphoid cells (ILC2) are a novel population of lineage-negative cells that produce high levels of Th2 cytokines IL-5 and IL-13. ILC2 are found in human respiratory and gastrointestinal tissue as well as in skin.
Doherty, Taylor A +2 more
core +2 more sources
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Ear, nose, & throat journal, 2020 Biologic therapy is a new treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Currently, the only biologic with Food and Drug Administration–approval status for CRSwNP is dupilumab.
G. Patel, Anju T Peters
semanticscholar +1 more source